Literature DB >> 679148

A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model.

K Lundholm, S Edström, L Ekman, I Karlberg, A C Bylund, T Scherstén.   

Abstract

Metabolic alterations in skeletal muscles and liver tissue from cancer patients were compared with corresponding alterations in mice (C-57) with sarcoma (MCG-101). In tumor-bearing man and mice similar changes in enzyme activities and in protein turnover were found. Glycolytic and oxidative enzyme activities were decreased in skeletal muscle tissue. Tumor-associated increase in lysosomal enzyme activities was found in both species. Leucine was incorporated into skeletal muscle proteins at a lower rate and into hepatic proteins at a higher rate in both species with malignant tumor. In tumor-bearing mice ribosome profiles from skeletal muscle, heart muscle and liver showed a preponderance of slowly sedimenting units of polyribosomes suggesting that initiation of protein synthesis may be a rate limiting step. The metabolic host reactions in tumor-bearing mice were similar to those in cancer patients implying that experimental tumors are relevant to use for analysis of mechanisms behind the development of cancer cachexia in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679148     DOI: 10.1002/1097-0142(197808)42:2<453::aid-cncr2820420212>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Metabolic effects of nutritional support to cancer patients.

Authors:  L Lindmark; L Ekman
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

2.  Amino acid metabolism in tumour-bearing mice.

Authors:  S Rivera; J Azcón-Bieto; F J López-Soriano; M Miralpeix; J M Argilés
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

3.  Nutrition and the cancer patient.

Authors:  A J Strain; G C Easty; A M Neville
Journal:  Br Med J       Date:  1978-11-04

4.  Antitumor drug toxicity in tumor-free and tumor-bearing mice.

Authors:  S D Harrison; H D Giles; E P Denine
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 5.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

6.  Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy.

Authors:  H F Starnes; R S Warren; M F Brennan
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia.

Authors:  L Tessitore; G Bonelli; F M Baccino
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

8.  Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer.

Authors:  K C Fearon; D C McMillan; T Preston; F P Winstanley; A M Cruickshank; A Shenkin
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

Review 9.  Muscle wasting in animal models of severe illness.

Authors:  Milan Holecek
Journal:  Int J Exp Pathol       Date:  2012-05-08       Impact factor: 1.925

10.  Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity.

Authors:  L Simpson-Herren; P E Noker; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.